These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31465261)

  • 1. The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues.
    Sio TT; Mohindra P; Yu NY; Ashman JB; Daniels TB; Merrell KW; Schild SE
    J Clin Oncol; 2019 Oct; 37(29):2697-2699. PubMed ID: 31465261
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
    Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
    Chang JY; Bezjak A; Mornex F;
    J Thorac Oncol; 2015 Apr; 10(4):577-85. PubMed ID: 25514807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
    Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
    Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.
    Haseltine JM; Rimner A; Shepherd AF; Wu AJ; Gelblum DY; Shaverdian N; Gomez DR; Simone CB
    Chin Clin Oncol; 2020 Jun; 9(3):39. PubMed ID: 32008333
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Aridgides P; Bogart J
    Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
    Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Mason D; Murthy S; Rice TW; Mazzone P; Machuzak M; Mekhail T; Videtic GM
    J Thorac Oncol; 2009 Aug; 4(8):976-82. PubMed ID: 19633473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SBRT effective for inoperable early-stage lung cancer.
    Cancer Discov; 2014 Dec; 4(12):OF2. PubMed ID: 25477119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD; Fernando HC
    Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Yu T; Shin IS; Yoon WS; Rim CH
    Clin Lung Cancer; 2019 Jul; 20(4):e452-e462. PubMed ID: 31029573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.
    Christie NA; Pennathur A; Burton SA; Luketich JD
    Semin Thorac Cardiovasc Surg; 2008; 20(4):290-7. PubMed ID: 19251167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy for nonsmall cell lung cancer.
    Ball D
    Curr Opin Pulm Med; 2008 Jul; 14(4):297-302. PubMed ID: 18520262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
    Lee S; Song SY; Kim SS; Choi W; Je HU; Back GM; Cho B; Jeong SY; Choi EK
    Clin Lung Cancer; 2018 Mar; 19(2):e253-e261. PubMed ID: 29196082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
    Phillips I; Sandhu S; Lüchtenborg M; Harden S
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.